Skip to main content
Log in

Whole-tumor histogram analysis of diffusion and perfusion metrics for noninvasive pediatric glioma grading

  • Paediatric Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Purpose

An accurate assessment of the World Health Organization grade is vital for patients with pediatric gliomas to direct treatment planning. We aim to evaluate the diagnostic performance of whole-tumor histogram analysis of diffusion-weighted imaging (DWI) and dynamic susceptibility contrast-enhanced perfusion-weighted imaging (DSC-PWI) for differentiating pediatric high-grade gliomas from pediatric low-grade gliomas.

Methods

Sixty-eight pediatric patients (mean age, 10.47 ± 4.37 years; 42 boys) with histologically confirmed gliomas underwent preoperative MR examination. The conventional MRI features and whole-tumor histogram features extracted from apparent diffusion coefficient (ADC) and cerebral blood volume (CBV) maps were analyzed, respectively. Receiver operating characteristic curves and the binary logistic regression analysis were performed to determine the diagnostic performance of parameters.

Results

For conventional MRI features, location, hemorrhage and tumor margin showed significant difference between pediatric high- and low-grade gliomas (all, P < .05). For advanced MRI parameters, ten histogram features of ADC and CBV showed significant differences between pediatric high- and low-grade gliomas (all, P < .05). The diagnostic performance of the combination of DSC-PWI and DWI (AUC = 0.976, sensitivity = 100%, NPV = 100%) is superior to conventional MRI or DWI model, respectively (AUCcMRI = 0.700, AUCDWI = 0.830; both, P < .05).

Conclusion

The whole-tumor histogram analysis of DWI and DSC-PWI is a promising method for grading pediatric gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Jones DT, Mulholland SA, Pearson DM et al (2011) Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their pediatric counterparts. Acta Neuropathol 121:753–761. https://doi.org/10.1007/s00401-011-0810-6

    Article  PubMed  Google Scholar 

  2. Paugh BS, Qu C, Jones C et al (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28:3061–3068. https://doi.org/10.1200/JCO.2009.26.7252

    Article  PubMed  PubMed Central  Google Scholar 

  3. Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kline C, Felton E, Allen IE, Tahir P, Mueller S (2018) Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis. J Neurooncol 137:103–110. https://doi.org/10.1007/s11060-017-2701-8

    Article  PubMed  Google Scholar 

  5. Zhang HW, Lyu GW, He WJ et al (2020) DSC and DCE Histogram Analyses of Glioma Biomarkers, Including IDH, MGMT, and TERT, on Differentiation and Survival. Acad Radiol 27:e263–e271. https://doi.org/10.1016/j.acra.2019.12.010

    Article  PubMed  Google Scholar 

  6. Xing Z, Yang X, She D, Lin Y, Zhang Y, Cao D (2017) IDH Noninvasive Assessment of Mutational Status in World Health Organization Grade II and III Astrocytomas Using DWI and DSC-PWI Combined with Conventional MR Imaging. AJNR Am J Neuroradiol 38:1138–1144. https://doi.org/10.3174/ajnr.A5171

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Patel P, Baradaran H, Delgado D et al (2017) MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis. Neuro Oncol 19:118–127. https://doi.org/10.1093/neuonc/now148

    Article  PubMed  Google Scholar 

  8. Morana G, Tortora D, Staglianò S et al (2018) Pediatric astrocytic tumor grading: comparison between arterial spin labeling and dynamic susceptibility contrast MRI perfusion. Neuroradiology 60:437–446. https://doi.org/10.1007/s00234-018-1992-6

    Article  PubMed  Google Scholar 

  9. You SH, Choi SH, Kim TM et al (2018) Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging. Radiology 286:981–991. https://doi.org/10.1148/radiol.2017170764

    Article  PubMed  Google Scholar 

  10. Togao O, Hiwatashi A, Yamashita K et al (2016) Differentiation of high-grade and low-grade diffuse gliomas by intravoxel incoherent motion MR imaging. Neuro Oncol 18:132–141. https://doi.org/10.1093/neuonc/nov147

    Article  PubMed  Google Scholar 

  11. Server A, Kulle B, Gadmar ØB, Josefsen R, Kumar T, Nakstad PH (2011) Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. Eur J Radiol 80:462–470. https://doi.org/10.1016/j.ejrad.2010.07.017

    Article  PubMed  Google Scholar 

  12. Zhu Q, Zou J, Ye J et al (2022) Comparative study of conventional ROI-based and volumetric histogram analysis derived from CT enhancement in differentiating malignant and benign renal tumors. Br J Radiol 95:20210801. https://doi.org/10.1259/bjr.20210801

    Article  PubMed  Google Scholar 

  13. Rezvani HR, Khoshpouri P, Ghadimi M et al (2020) Comparison between ROI-based and volumetric measurements in quantifying heterogeneity of liver stiffness using MR elastography. Eur Radiol 30:1609–1615. https://doi.org/10.1007/s00330-019-06478-0

    Article  Google Scholar 

  14. Ahn SJ, Shin HJ, Chang JH, Lee SK (2014) Differentiation between primary cerebral lymphoma and glioblastoma using the apparent diffusion coefficient comparison of three different ROI methods. PLoS One 9:e112948. https://doi.org/10.1371/journal.pone.0112948

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Gao A, Zhang H, Yan X et al (2022) Whole-Tumor Histogram Analysis of Multiple Diffusion Metrics for Glioma Genotyping. Radiology 302:652–661. https://doi.org/10.1148/radiol.210820

    Article  PubMed  Google Scholar 

  16. Vajapeyam S, Brown D, Ziaei A et al (2022) ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor Consortium. AJNR Am J Neuroradiol 43:455–461. https://doi.org/10.3174/ajnr.A7433

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Xu Z, Yang L, Liu Q et al (2022) Machine Learning of Dose-Volume Histogram Parameters Predicting Overall Survival in Patients with Cervical Cancer Treated with Definitive Radiotherapy. J Oncol 2022:2643376. https://doi.org/10.1016/j.radonc.2020.11.030

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. De RR, Maris B, Cardobi N et al (2018) Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? Eur Radiol 28:2582–2591. https://doi.org/10.1007/s00330-017-5236-7

    Article  Google Scholar 

  19. Sturm D, Pfister SM, Jones DTW (2017) Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management. J Clin Oncol 35:2370–2377. https://doi.org/10.1200/JCO.2017.73.0242

    Article  PubMed  Google Scholar 

  20. Chiang JC, Ellison DW (2017) Molecular pathology of pediatric central nervous system tumours. J Pathol 241:159–172. https://doi.org/10.1002/path.4813

    Article  CAS  PubMed  Google Scholar 

  21. Cancer Imaging Archive website (2020) VASARI Research Project. https://www.wiki.cancerimagingarchive.net/display/Public/VASARI+Research+Project. Updated March 20, 2020. Accessed July 30, 2020.

  22. Qi XX, Shi DF, Ren SX et al (2018) Histogram analysis of diffusion kurtosis imaging derived maps may distinguish between low and high grade gliomas before surgery. Eur Radiol 28:1748–1755. https://doi.org/10.1007/s00330-017-5108-1

    Article  PubMed  Google Scholar 

  23. Du N, Zhou X, Mao R et al (2022) Preoperative and Noninvasive Prediction of Gliomas Histopathological Grades and IDH Molecular Types Using Multiple MRI Characteristics. Front Oncol 12:873839. https://doi.org/10.3389/fonc.2022.873839

    Article  PubMed  PubMed Central  Google Scholar 

  24. Yao R, Cheng A, Liu M, Zhang Z, Jin B, Yu H (2021) The Diagnostic Value of Apparent Diffusion Coefficient and Proton Magnetic Resonance Spectroscopy in the Grading of Pediatric Gliomas. J Comput Assist Tomogr 45:269–276. https://doi.org/10.1097/RCT.0000000000001130

    Article  PubMed  Google Scholar 

  25. Van SL, Kouwenberg V, Meijer F, Smits M, Henssen D (2022) A systematic review and meta-analysis on the differentiation of glioma grade and mutational status by use of perfusion-based magnetic resonance imaging. Insights Imaging 13:102. https://doi.org/10.1186/s13244-022-01230-7

    Article  Google Scholar 

  26. Sudre CH, Panovska-Griffiths J, Sanverdi E et al (2020) Machine learning assisted DSC-MRI radiomics as a tool for glioma classification by grade and mutation status. BMC Med Inform Decis Mak 20:149. https://doi.org/10.1186/s12911-020-01163-5

    Article  PubMed  PubMed Central  Google Scholar 

  27. Falk A, Fahlström M, Rostrup E et al (2014) Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach. Neuroradiology 56:1031–1038. https://doi.org/10.1007/s00234-014-1426-z

    Article  PubMed  Google Scholar 

  28. Zhang L, He L, Lugano R et al (2018) IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas. Neuro Oncol 20:1505–1516. https://doi.org/10.1093/neuonc/noy088

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was supported by the Leading Project of the Department of Science and Technology of Fujian Province (grant number 2020Y0025), the National Natural Science Foundation of China (grant number 82071869), and the Startup Fund for Scientific Research, Fujian Medical University (grant number 2018QH1048), the Young and Middle-aged Key Personnel Training Project of Fujian Provincial Health Commission (grant number 2021GGA025), and the Young and Middle-aged Key Personnel Training Project of Fujian Provincial Health Commission (grant number 2020GGA049s).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dairong Cao.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

For this type of study formal consent is not required.

Informed consent

The study was approved by our institutional review committee. Informed consent was waived off due to the retrospective nature of the study.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 15 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Su, Y., Kang, J., Lin, X. et al. Whole-tumor histogram analysis of diffusion and perfusion metrics for noninvasive pediatric glioma grading. Neuroradiology 65, 1063–1071 (2023). https://doi.org/10.1007/s00234-023-03145-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-023-03145-6

Keywords

Navigation